CADENCE CAPITAL MANAGEMENT LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$365,000
-69.0%
52,644
-56.1%
0.03%
-60.6%
Q2 2015$1,178,000
+8.1%
119,973
-2.5%
0.07%
-1.5%
Q1 2015$1,090,000
-10.3%
123,044
-11.3%
0.07%
-5.6%
Q4 2014$1,215,000
+13.8%
138,714
-10.5%
0.07%
+26.8%
Q3 2014$1,068,000155,0100.06%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Sensato Investors LLC 1,552,482$13,755,0002.96%
Nantahala Capital Management 1,522,625$13,490,0002.24%
GLOBEFLEX CAPITAL L P 150,138$1,330,0000.25%
Ativo Capital Management LLC 71,563$634,0000.25%
MCKINLEY CAPITAL MANAGEMENT LLC 543,110$4,812,0000.19%
RFG Advisory, LLC 24,700$208,0000.16%
GSA CAPITAL PARTNERS LLP 345,833$3,064,0000.12%
Spark Investment Management LLC 95,900$849,0000.12%
Numeric Investors LLC 1,002,814$8,885,0000.11%
ClariVest Asset Management LLC 384,222$3,404,0000.10%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders